Automated Endoscopy Reprocessor (AER) can enhance consistency, efficiency, and reliability of endoscope reprocessing by automating and standardizing various important reprocessing stages, eventually reducing the possibility of human error. AERs reduces exposure to harmful chemical germicides and can decrease health problems related to endoscopes reprocessing. Therefore, American Society for Gastrointestinal Endoscopy (ASGE) strongly recommends the use of AERs for endoscope reprocessing. The World Gastroenterology Organization (WGO) recommends the use of AER as the most extensive options for diagnostics improvement where sufficient resources are available. However, it also states that conversion from manual use to AERs, can generate cost and revenue offsets to produce direct financial gains for some endoscopy units in emerging economies.
Market Dynamics
Major factors driving growth of the automated endoscopy reprocessor market includes rising adoption of AERs in hospitals for infection control and prevention coupled with increasing rate of gastrointestinal disorders. According to Center for Disease Control and Prevention report of 2016, the number of adults diagnosed with ulcers were 14.7 million in the U.S. Furthermore, increasing number of endoscopy procedures and demand for minimally invasive surgeries due low hospital stay cost is also expected to fuel automated endoscope reprocessor market growth. However, risk of infection post endoscopic reprocessing procedures and complications related with AERs can negatively impact adoption of automated endoscope reprocessors, thus affecting growth of the market during the forecast period. Product recalls due to stringent government regulations is also a major factor hindering the market growth.
Key features of the study:
- This report provides in-depth analysis of automated endoscopy reprocessor market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global automated endoscopy reprocessor market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Cantel Medical Corp., Johnson & Johnson, Laboratoires Anios, Olympus Corporation, Steelco SpA, Steris Plc., Getinge Group, Hoya Group, and Metall Zug AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global automated endoscopy reprocessor market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the automated endoscopy reprocessor market
Detailed Segmentation:
- Global Automated Endoscopy Reprocessor Market, By Product Type:
- Single Basin
- Double Basin
- Global Automated Endoscopy Reprocessor Market, By Modality:
- Global Automated Endoscopy Reprocessor Market, By End User:
- Hospital
- Diagnostics Laboratories
- Ambulatory Centers
- Global Automated Endoscopy Reprocessor Market, By Geography:
- North America
- By Product Type:
- Single Basin
- Double Basin
- By Modality:
- By End User:
- Hospital
- Diagnostics Laboratories
- Ambulatory Centers
- By Country:
- Latin America
- By Product Type:
- Single Basin
- Double Basin
- By Modality:
- By End User:
- Hospital
- Diagnostics Laboratories
- Ambulatory Centers
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Single Basin
- Double Basin
- By Modality:
- By End User:
- Hospital
- Diagnostics Laboratories
- Ambulatory Centers
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Single Basin
- Double Basin
- By Modality:
- By End User:
- Hospital
- Diagnostics Laboratories
- Ambulatory Centers
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Single Basin
- Double Basin
- By Modality:
- By End User:
- Hospital
- Diagnostics Laboratories
- Ambulatory Centers
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Single Basin
- Double Basin
- By Modality:
- By End User:
- Hospital
- Diagnostics Laboratories
- Ambulatory Centers
- By Country:
- North Africa
- South Africa
- Central Africa
- Company Profiles
- Cantel Medical Corp.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Market Strategy
- Steris Plc.
- Olympus Corporation
- Johnson & Johnson
- Steelco SpA
- Getinge Group
- Hoya Group
- Metall Zug AG
- Laboratoires Anios
“*” marked represents similar segmentation in other categories in the respective section.
